China Resources Pharmaceutical (03320.HK): China Resources Boya Bio's net profit for the first three quarters was RMB 60.5883 million, a year-on-year decrease of 82.34%.

Zhitong Finance APP News, China Resources Pharmaceutical (03320.HK) announced that China Resources Boya Bio-pharmaceutical for the nine months ended September 30, 2026 achieved total operating revenue of RMB 847 million (same unit below), a year-on-year decrease of 42.54%; net profit of RMB 60.5883 million, a year-on-year decrease of 82.34%.